Cita APA

Kyriakos, G., Quiles-Sanchez, L. V., Garmpi, A., Farmaki, P., Kyre, K., Savvanis, S., . . . Memi, E. (2020). SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There is a Class Effect? New Insights from the EMPA-REG OUTCOME trial and the CVD-REAL Study. Curr Cardiol Rev.

Citación estilo Chicago

Kyriakos, Georgios, Lourdes V. Quiles-Sanchez, Anna Garmpi, Paraskevi Farmaki, Konstantina Kyre, Spyridon Savvanis, Vasileios K. Antoniou, y Eleni Memi. "SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There Is a Class Effect? New Insights From the EMPA-REG OUTCOME Trial and the CVD-REAL Study." Curr Cardiol Rev 2020.

Cita MLA

Kyriakos, Georgios, et al. "SGLT2 Inhibitors and Cardiovascular Outcomes: Do They Differ or There Is a Class Effect? New Insights From the EMPA-REG OUTCOME Trial and the CVD-REAL Study." Curr Cardiol Rev 2020.